Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
Description: Corcept Therapeutics Incorporated, a pharmaceutical company, is engaged in the discovery, development, and commercialization of drugs for the treatment of metabolic, psychiatric, and oncologic disorders in the United States. The company focuses on disorders that are associated with a steroid hormone called cortisol. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing?s syndrome, who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also developing mifepristone, an active ingredient in Korlym, which is in Phase III study for treatment of the psychotic features of psychotic depression; and in Phase I study for the treatment of triple-negative breast cancer. In addition, it discovers and develops three series of novel selective GR-II antagonists. The company has research and development agreements with Argenta D
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||72.68%||Sales Growth - Q/Q||12.07%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-46.21%||ROE||-210.77%||ROI|
|Current Ratio||2.85||Quick Ratio||2.76||Long Term Debt/Equity||0.77||Debt Ratio||1.47|
|Gross Margin||96.87%||Operating Margin||-58.27%||Net Profit Margin||-69.1%||Dividend Payout Ratio|
|Cash From Financing Activities||15.52 M||Cash From Investing Activities||-30 K||Cash From Operating Activities||-1.78 M||Gross Profit||9.8 M|
|Net Profit||-4.83 M||Operating Profit||-4.03 M||Total Assets||48.22 M||Total Current Assets||44.19 M|
|Total Current Liabilities||15.53 M||Total Debt||32.78 M||Total Liabilities||37.65 M||Total Revenue||10.1 M|
|High 52 week||17.19||Low 52 week||9.78||Last close||14.36||Last change||2.21%|
|RSI||43.75||Average true range||0.45||Beta||0.99||Volume||325.31 K|
|Simple moving average 20 days||1.81%||Simple moving average 50 days||7.91%||Simple moving average 200 days||18.95%|
|Performance Week||2.21%||Performance Month||8.05%||Performance Quart||34.58%||Performance Half||21.9%|
|Performance Year||17.32%||Performance Year-to-date||7.49%||Volatility daily||1.61%||Volatility weekly||3.6%|
|Volatility monthly||7.37%||Volatility yearly||25.52%||Relative Volume||267.92%||Average Volume||720.16 K|
|New High||New Low|
2019-11-19 08:51:01 | Can The Uptrend Continue for Corcept Therapeutics?
2019-11-14 08:52:01 | Options Traders Expect Huge Moves in Corcept CORT Stock
2019-11-08 18:08:00 | Edited Transcript of CORT earnings conference call or presentation 7-Nov-19 10:00pm GMT
2019-11-08 10:31:03 | Corcept CORT Earnings Beat in Q3, Korlym Boosts Sales
2019-11-07 19:35:12 | Corcept Therapeutics CORT Surpasses Q3 Earnings and Revenue Estimates
2019-11-04 06:51:47 | Is Corcept Therapeutics Incorporated NASDAQ:CORT A High Quality Stock To Own?
2019-10-27 14:04:38 | Did Hedge Funds Drop The Ball On Corcept Therapeutics Incorporated CORT ?
2019-10-14 10:10:02 | Why Corcept CORT is Poised to Beat Earnings Estimates Again
2019-09-18 08:30:00 | Corcept Therapeutics Appoints Kimberly Park to Board of Directors
2019-09-16 10:43:12 | Corcept Therapeutics Incorporated NASDAQ:CORT: A Fundamentally Attractive Investment
2019-09-13 13:54:09 | 5 Health Care Stocks Gurus Are Buying
2019-08-31 09:31:01 | Corcept CORT Up 15.1% Since Last Earnings Report: Can It Continue?
2019-08-27 13:05:03 | Is Corcept Therapeutics Incorporated's NASDAQ:CORT CEO Overpaid Relative To Its Peers?
2019-08-05 09:18:01 | Corcept's CORT Earnings & Revenues Miss Estimates in Q2
2019-08-03 08:53:01 | Edited Transcript of CORT earnings conference call or presentation 1-Aug-19 9:00pm GMT
2019-08-03 00:18:12 | Corcept Therapeutics Incorporated CORT Q2 Earnings Call Transcript
2019-08-01 19:05:11 | Corcept Therapeutics CORT Q2 Earnings Beat Estimates
2019-08-01 08:00:42 | Does Corcept Therapeutics Incorporated NASDAQ:CORT Have A High Beta?
2019-06-19 12:41:52 | Corcept Therapeutics Incorporated NASDAQ:CORT: Poised For Long Term Success?
2019-06-08 09:30:01 | Corcept CORT Down 11.3% Since Last Earnings Report: Can It Rebound?
2019-06-01 11:37:25 | The Week Ahead In Biotech: ASCO Presentations Pick Up The Pace
2019-05-30 13:21:31 | Is Corcept Therapeutics Incorporated's NASDAQ:CORT P/E Ratio Really That Good?
2019-05-28 08:05:00 | Corcept Therapeutics to Present Data from Phase 1/2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Solid Tumors at the American Society of Clinical Oncology Annual Meeting
2019-05-16 22:00:00 | Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Corcept, Mobile TeleSystems, Healthcare Services, and American Renal and Encourages Investors to Contact the Firm
2019-05-13 15:00:00 | CRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class Action
2019-05-13 10:43:00 | DEADLINE MONDAY REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-05-10 15:50:00 | 3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-05-10 12:00:00 | DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-05-10 11:56:38 | Corcept Therapeutics Incorporated CORT Q1 2019 Earnings Call Transcript
2019-05-10 07:19:47 | Edited Transcript of CORT earnings conference call or presentation 9-May-19 9:00pm GMT
2019-05-09 19:25:11 | Corcept Therapeutics CORT Q1 Earnings Top Estimates
2019-05-09 18:23:01 | Corcept: 1Q Earnings Snapshot